{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:11:09Z","timestamp":1792822269392,"version":"4.5.0"},"reference-count":101,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"unspecified","delay-in-days":40,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Strongbridge Biopharma"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2021,7,4]]},"DOI":"10.1080\/17446651.2021.1945440","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T04:38:43Z","timestamp":1624855123000},"page":"159-174","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Levoketoconazole: a novel treatment for endogenous Cushing's syndrome"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"first","affiliation":[{"name":"Diabetes and Clinical Nutrition, Department of Neurological Surgery, and Pituitary Center","place":["Portland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-6181","authenticated-orcid":false,"given":"Richard J.","family":"Auchus","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School","place":["Ann Arbor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9632-1348","authenticated-orcid":false,"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Federico II Di Napoli","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2244","authenticated-orcid":false,"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, Department of Medicine, Division of Endocrinology, and Pituitary Center","place":["Baltimore, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6087-7136","authenticated-orcid":false,"given":"Sabina","family":"Zacharieva","sequence":"additional","affiliation":[{"name":"Department of Endocrinology","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4359-4622","authenticated-orcid":false,"given":"Beverly M. K.","family":"Biller","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Neuroendocrine and Pituitary Tumor Clinical Center","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0742-1"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02486.x"},{"issue":"1","key":"e_1_3_5_5_1","first-page":"117","article-title":"Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study","volume":"86","author":"Lindholm J","unstructured":"Lindholm J, Juul S, J\u00f8rgensen JO, et al. Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study. J Clin Endocrinol Metab. 2001 Jan;86(1)117\u2013123.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3582"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14014"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2012.02.110227"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30005-5"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0556"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)00086-3"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00129"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0735-z"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61375-1"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S44336"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-45950-9_10"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0467"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1818"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1048"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01128-7"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0092"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0265"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.04.004"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.01.006"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP171787.OR"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30155-4"},{"key":"e_1_3_5_27_1","unstructured":"Ketoconazole tablets USP 200 mg. Haifa Bay Israel: Taro Pharmaceutical Industries Ltd.; 2017."},{"key":"e_1_3_5_28_1","unstructured":"European Medicines Agency. Ketoconazole HRA 200 mg tablets: summary of product characteristics. London. 2014."},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1622"},{"key":"e_1_3_5_30_1","unstructured":"European Medicines Agency Committee for Medicinal Products for Human Use. Ketoconazole HRA: assessment report. London. 2014."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04093.x"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.05.021"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903381411"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00093a015"},{"issue":"2","key":"e_1_3_5_35_1","article-title":"2S,4R-ketoconazole is the relevant enantiomer of ketoconazole for cortisol synthesis inhibition: steroidogenic P450s inhibition involves multiple mechanisms [abstract]","volume":"39","author":"Auchus RJ","year":"2018","unstructured":"Auchus RJ, Wu Y, Liu J, et al. 2S,4R-ketoconazole is the relevant enantiomer of ketoconazole for cortisol synthesis inhibition: steroidogenic P450s inhibition involves multiple mechanisms [abstract]. Endocr Rev. 2018;39(2 suppl). https:\/\/www.endocrine.org\/meetings-and-events\/endo-annual-meetings?ID=46236\u00a0","journal-title":"Endocr Rev"},{"key":"e_1_3_5_36_1","volume-title":"98th Annual Meeting and Expo of the Endocrine Society (ENDO)","author":"Thieroff-Ekerdt R","unstructured":"Thieroff-Ekerdt R, Lavin P, Abou-Gharbia M, et al. Pharmacology of COR-003 (levoketoconazole), an investigational treatment for endogenous Cushing's syndrome. 98th Annual Meeting and Expo of the Endocrine Society (ENDO); 2016 Apr 1\u20134; Boston, MA."},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.10.016"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa989"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112662"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R900010-JLR200"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111286"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/chir.10294"},{"key":"e_1_3_5_43_1","first-page":"31","article-title":"Pharmacological modulation of CRH-stimulated ACTH secretion by ketokonazole","volume":"16","author":"Stalla GK","year":"1987","unstructured":"Stalla GK, Stalla J, Loeffler JP, et al. Pharmacological modulation of CRH-stimulated ACTH secretion by ketokonazole. Horm Metab Res Suppl. 1987;16:31\u201336.","journal-title":"Horm Metab Res Suppl"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-019-00361-6"},{"key":"e_1_3_5_45_1","first-page":"3","article-title":"Ketoconazole induces inhibition of cell viability and apoptosis in an ACTH-secreting tumour cell line model [abstract EP 927]","volume":"49","author":"Patalano R","year":"2017","unstructured":"Patalano R, Pivonello C, Solari D, et al. Ketoconazole induces inhibition of cell viability and apoptosis in an ACTH-secreting tumour cell line model [abstract EP 927]. Endocr Abst. 2017;49:3.","journal-title":"Endocr Abst"},{"key":"e_1_3_5_46_1","volume-title":"American Society of Clinical Pharmacology and Therapeutics (ASCPT)","author":"Boudriau S","unstructured":"Boudriau S, Demnati R, Swearingen D, et al. Differential effects of co-administration of racemic ketoconazole and levdexketoconazole of the pharmacokinetic profile of atorvastatin. American Society of Clinical Pharmacology and Therapeutics (ASCPT); 2008 Apr 2\u20135; Orlando, FL."},{"key":"e_1_3_5_47_1","volume-title":"18th European Congress of Endocrinology (ECE)","author":"Thieroff-Ekerdt RI","unstructured":"Thieroff-Ekerdt RI, Mould DR Differential pharmacokinetics of levoketoconazole (COR-003), the single 2S,4R-enantiomer of ketoconazole, a new investigational drug for the treatment of Cushing's syndrome. 18th European Congress of Endocrinology (ECE); 2016 May 28\u201331; Munich, Germany."},{"key":"e_1_3_5_48_1","volume-title":"43rd Interscience Conference on Antimicrobial Agents (ICAAC)","author":"Gerber JG","unstructured":"Gerber JG, Dilaghanian S, Gal J, et al. Stereoselective pharmacokinetics (PK) of oral ketoconazole (K) in healthy subjects. 43rd Interscience Conference on Antimicrobial Agents (ICAAC); 2003 Sept 14\u201317; Chicago, IL."},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1671"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.9.1765"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.04.078"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30313-4"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3628"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0514"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.02.003"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0695"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00375"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-20-1309"},{"key":"e_1_3_5_59_1","volume-title":"16th International Pituitary Congress","author":"Fleseriu M","unstructured":"Fleseriu M, Pivonello R, Elenkova A, et al. Levoketoconazole in the treatment of endogenous Cushing's syndrome: secondary endpoint results from a phase 3 study (SONICS). 16th International Pituitary Congress; 2019 Mar 20\u201322; New Orleans, LA."},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101490"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2616"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-020-01103-6"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01721288"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb03547.x"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1982.00340250097015"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-4-732"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.6.1073"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1991.tb01492.x"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12490"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1159\/000443864"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0860-9"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00284"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.595894"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0886"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(84)80021-9"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6569.419"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707537"},{"issue":"1","key":"e_1_3_5_78_1","first-page":"26","article-title":"Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome","volume":"67","author":"Moncet D","year":"2007","unstructured":"Moncet D, Morando DJ, Pitoia F, et al. Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome. Medicina (B Aires). 2007;67(1):26\u201331.","journal-title":"Medicina (B Aires)"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb03517.x"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0358"},{"key":"e_1_3_5_81_1","unstructured":"Signifor (pasireotide) injection for subcutaneous use. East Hanover NJ: Novartis Pharmaceuticals. 2020."},{"key":"e_1_3_5_82_1","unstructured":"European Medicines Agency. Signifor (pasireotide) injection for subcutaneous use: summary of product characteristics. Amsterdam. 2016."},{"key":"e_1_3_5_83_1","unstructured":"Isturisa (osilodrostat) tablets for oral use. Lebanon NJ: Recordati Rare Disease Inc. 2020."},{"key":"e_1_3_5_84_1","volume-title":"Isturisa (osilodrostat): summary of product characteristics","author":"European Medicines Agency","year":"2020","unstructured":"European Medicines Agency. Isturisa (osilodrostat): summary of product characteristics. Amsterdam. 2020."},{"key":"e_1_3_5_85_1","unstructured":"Korlym (mifepristone) 300 mg tablets. Menlo Park CA: Corcept Therapeutics Incorporated. 2019."},{"key":"e_1_3_5_86_1","volume-title":"Metopirone 250 mg: summary of product characateristics","year":"2017","unstructured":"Metopirone 250 mg: summary of product characateristics. London: HRA Pharma UK and Ireland Limited.\u00a02017."},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0692-z"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30240-0"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1843"},{"key":"e_1_3_5_90_1","first-page":"60","article-title":"ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies","volume":"16","author":"Boscaro M","year":"1987","unstructured":"Boscaro M, Sonino N, Rampazzo A, et al. ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies. Horm Metab Res Suppl. 1987;16:60\u201362.","journal-title":"Horm Metab Res Suppl"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302007000700014"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03618.x"},{"issue":"6","key":"e_1_3_5_93_1","first-page":"485","article-title":"No effect of ketoconazole on thyroid function of normal subjects and hypothyroid patients","volume":"8","author":"De Pedrini P","year":"1988","unstructured":"De Pedrini P, Tommaselli A, Montemurro G, et al. No effect of ketoconazole on thyroid function of normal subjects and hypothyroid patients. Int J Clin Pharmacol Res. 1988;8(6):485\u2013488.","journal-title":"Int J Clin Pharmacol Res"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80346-9"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-5-987"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1300333"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-5-1121"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105743"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30326-1"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa778"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1000094"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.70.AEP678"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa046.1129"}],"container-title":["Expert Review of Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17446651.2021.1945440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:42:28Z","timestamp":1772757748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17446651.2021.1945440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,4]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7,4]]}},"alternative-id":["10.1080\/17446651.2021.1945440"],"URL":"https:\/\/doi.org\/10.1080\/17446651.2021.1945440","relation":{},"ISSN":["1744-6651","1744-8417"],"issn-type":[{"value":"1744-6651","type":"print"},{"value":"1744-8417","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iere20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}